[ad_1] It was a tumultuous fall for AbbVie. In the weeks leading up to the pharmaceutical company's third quarter earnings report, on Nov. 2, the group resolved a series of patent litigation …
Read More »AbbVie stays busy while Humira copiers are on sale in Europe
